Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, Chiadi E., Rangaswami, Janani, Chow, Sheryl L., Neeland, Ian J., Tuttle, Katherine R., Khan, Sadiya S., Coresh, Josef, Mathew, Roy O. +22 more·2023·Circulation

DOI 10.1161/cir.0000000000001184

Cited by (1,000)

Items 201–300 of 1,000

Cardiovascular–kidney–metabolic syndrome: a comprehensive review of pathophysiology, epidemiology, diagnosis, and management
Stanislovas S. Jankauskas, Klara Komici, Fahimeh Varzideh, Luigi Simone Aversa, Urna Kansakar, Maria Luisa D'Onghia, Shivangi Pande, Pasquale Mone, Gaetano Santulli · 2026 · Cardiovascular Diabetology
Allocation of Semaglutide According to Coronary Artery Calcium and BMI
Alexander C. Razavi, Alexander M. Cao Zhang, Zeina Dardari, Khurram Nasir, Michael Khorsandi, Martin Bødtker Mortensen, Mouaz Husayn Al-Mallah, Michael David Shapiro, Melissa A. Daubert, Roger Scott Blumenthal et al. · 2025 · JACC. Cardiovascular imaging
Prevalence Rates of Abdominal Obesity, High Waist-to-Height Ratio and Excess Adiposity, and Their Associated Cardio-Kidney-Metabolic Factors: SIMETAP-AO Study
Antonio Ruiz‐García, Adalberto Serrano-Cumplido, Carlos Escobar, Ezequiel Arranz-Martínez, Vicente Pallarés‐Carratalá · 2024 · Nutrients
Sex differences in cardiovascular–kidney–metabolic risk factors associated with degenerative valvular heart disease
Yang Cheng, Ziang Li, Yong‐Gang Sui, Tianxin Long, Sijing Cheng, Xinli Guo, Chengqing Jiang, Haowen Ma, Haiyan Xu, Jie Qian et al. · 2025 · European Journal of Preventive Cardiology
Association between non-highdensity lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiovascular-kidney-metabolic syndrome: evidence from NHANES 2001–2018
Yang Duan, Ke Yang, Tianai Zhang, Xiang Guo, Qianran Yin, He Liu · 2025 · Frontiers in Nutrition
Metabolomic profiling reveals interindividual metabolic variability and its association with cardiovascular-kidney-metabolic syndrome risk
Meng Zhou, Wenxiu Sun, Yuhan Gao, Bei Jiang, Tianwei Sun, Rui Xu, Xiujuan Zhang, Qian Wang, Qiuhui Xuan, Shizhan Ma · 2025 · Cardiovascular Diabetology
Effectiveness of SGLT2 inhibitors, incretin-based therapies, and finerenone on cardiorenal outcomes: a meta-analysis and network meta-analysis
Arveen Shokravi, Jayant Seth, Nelson Lu, G.B. John Mancini · 2025 · Cardiovascular Diabetology – Endocrinology Reports
Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney disease
Joshua J. Neumiller, Radica Z. Alicic, Katherine R. Tuttle · 2023 · Clinical Kidney Journal
Overview of the Evolution of Hypertension: From Ancient Chinese Emperors to Today
George L. Bakris, Michael A. Weber · 2024 · Hypertension
Young-Onset Diabetes in East Asians: From Epidemiology to Precision Medicine
Juliana C.N. Chan, Chun Kwan O, Andrea O. Y. Luk · 2024 · Endocrinology and Metabolism
Prevalence of Cardiovascular‐Kidney‐Metabolic Stages in US Adolescents and Relationship to Social Determinants of Health
Baker‐Smith, Carissa M., Gauen, Abigail M., Petito, Lucia C., Khan, Sadiya S., Allen, Norrina B. · 2025 · Journal of the American Heart Association
Chronic kidney disease and menopausal health: An EMAS clinical guide
E. Cansu Cevik, C. Tamer Erel, İpek Betül Özçivit Erkan, Pantelis A. Sarafidis, Eleni Armeni, Ivan Fistonić, Timothy Hillard, Angelica Lindén Hirschberg, Błażej Męczekalski, Nicolás Mendoza et al. · 2024 · Maturitas
Risk stratification of metabolic disorder–associated kidney disease
Xin Ping Xu, Xian Shao, Fan Fan Hou · 2025 · Kidney International
Obesity and its management in primary care setting
Mahmoud Ashraf Ibrahim, Ebtesam M. Ba-Essa, Jessica A. Alvarez, Jason C. Baker, Vincenzo Bruni, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie Jane Davies, Francesco De Domenico et al. · 2025 · Journal of Diabetes and its Complications
Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study
Yixing Tian, Jinqi Wang, Tianyu Zhu, Xia Li, Haiping Zhang, Xiaoyu Zhao, Xinghua Yang, Yanxia Luo, Lixin Tao, Zhiyuan Wu et al. · 2025 · Nutrients
Vascular dysfunction in diabetes and pharmacotherapeutic opportunities: a focus on endothelial cell health
Ross A. Okazaki, Syed Husain Mustafa Rizvi, Rachael Lyons, Leili Behrooz, Naomi M. Hamburg · 2025 · American Journal of Physiology-Heart and Circulatory Physiology
Comparative analysis of 16 baseline obesity and lipid-related indices for cardiovascular disease risk prediction in adults with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study
Yilin Pan, Beibei Du, Long Feng, Jingru Bi · 2025 · Diabetology & Metabolic Syndrome
Use of risk assessment to guide decision-making for blood pressure management in the primary prevention of cardiovascular disease: a scientific statement from the American Heart Association and American College of Cardiology
Khan, Sadiya S., Lloyd-Jones, Donald M., Abdalla, Marwah, Bello, Natalie A., Blyler, Ciantel A., Carter, Jocelyn, Commodore-Mensah, Yvonne, Ferdinand, Keith C., Johnson, Heather M., Jones, Daniel et al. · 2025 · JACC
C-reactive protein–triglyceride glucose index predicts mortality in cardiovascular-kidney-metabolic syndrome stage 0–3: a prospective cohort study
Qianliang Ying, Fan He, Lei Wu, Qucheng Wei, Jian Xu · 2025 · Diabetology & Metabolic Syndrome
Exercise in CKM syndrome progression: a stage-specific approach to cardiovascular, metabolic, and renal health
Zacharias Papadakis · 2025 · Cardiovascular Diabetology
Association between estimated glucose disposal rate and incident cardiovascular disease in a population with Cardiovascular-Kidney-Metabolic syndrome stages 0–3: insights from CHARLS
Ziyi Tan, Dayong Zhou, Yaoliang Tang, Guijun Huo · 2025 · Frontiers in Cardiovascular Medicine
Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES
Chengzhi Hou, Xuanchun Huang, Jie Wang, Cong Chen, Chao Liu, Shuyuan Liu, Hongping Li · 2024 · Frontiers in Nutrition
The joint effect of triglyceride-glucose related indices and depression on cardio-renal-metabolic multimorbidity among middle-aged and older Chinese adults
Junping Liu, Zhaoyue Liu, Yue Zhou, Yaping Liu, Song Weijian, Nan Wang, Lin Wu, Xinru Liu, Xinle Yin, Yanfu Wang et al. · 2025 · Journal of Affective Disorders
South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population - An American society for preventive cardiology clinical practice statement
Anand K. Rohatgi, Sonia Savitri Anand, Meghana D. Gadgil, Unjali P. Gujral, Sneha S. Jain, Zulqarnain Javed, Manish K. Jha, Parag H. Joshi, Venkat Sanjay Manubolu, Khurram Nasir et al. · 2025 · American Journal of Preventive Cardiology
State-Level Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in the United States, 2011 to 2023
Ryan P. Chang, Tarang Parekh, Kobina Hagan, Zulqarnain Javed, John W. Ostrominski · 2025 · JACC Advances
Cardiovascular-kidney-metabolic syndrome modifies smoking-related risk for cardiovascular diseases: findings from an observational cohort study in UK Biobank
Xinhui Liu, Heng Zhang, Hongkai Li, Fuzhong Xue · 2025 · BMC Public Health
Association of Three Composite Inflammatory and Lipid Metabolism Indicators With Cardiovascular‐Kidney‐Metabolic Syndrome: A Cross‐Sectional Study Based on NHANES 1999–2020
Jiayuan Song, Ziyi Xu, Han Yu, Aimin Li, Yiying Liu, Meiying Jin · 2025 · Mediators of Inflammation
Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular–Kidney–Metabolic (CKM) Syndrome
Juan Guerrero‐Mauvecin, Natalia Villar-Gómez, Lucia Miño-Izquierdo, Adrián Povo‐Retana, Adrian Mario Ramos, Gema Ruiz‐Hurtado, María Dolores Sánchez-Niño, Alberto Ortíz, Ana Belen Sanz · 2025 · Antioxidants
Integrated Patient Digital and Biomimetic Twins for Precision Medicine: A Perspective
Mark T. Miedel, Mark E. Schurdak, Andrew M. Stern, Alejandro Soto–Gutiérrez, Eric V Strobl, Jaideep Behari, D. Lansing Taylor · 2025 · Seminars in Liver Disease
Transition of BMI Status From Childhood to Adulthood and Cardiovascular-Kidney-Metabolic Syndrome in Midlife: A 36-Year Cohort Study
Yang Wang, Yang Yang, Jing Chen, Ming‐Fei Du, Yue Sun, Dan Wang, Hao Jia, Gui‐Lin Hu, Zi‐Yue Man, Teng Zhang et al. · 2025 · Diabetes Care
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD
Alberto Ortíz, Motoko Yanagita, Hideki Yokoi, Roser Torrá · 2025 · Nephrology Dialysis Transplantation
Association between C-reactive protein-triglyceride glucose index and Future cardiovascular disease risk in a population with cardiovascular-Kidney-metabolic syndrome stage 0–3
Zhihui Lu, Long Li, Xiaolin Wang, Luo Lv, Shuling Rong, Bao Li · 2025 · Scientific Reports
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council
Francesco Giorgino, Fawaz Alzaïd, Anca Pantea Stoian, Juliana C.N. Chan, Linong Ji, William Lumu, Helard Manrique-Hurtado, Dı́dac Mauricio, Banshi Saboo, Peter Alexander Senior et al. · 2025 · Diabetologia
One Syndrome, Many Faces: A Unified Perspective on Heart Failure Phenotypes
IOANNIS A. PARASKEVAIDIS, Elias Tsougos, Christos Kourek · 2025 · International Journal of Molecular Sciences
Systemic Interactions in HFpEF: A Multiorgan Perspective on Pathways and Therapeutic Targets
Xinxin Cui, Yuxin Hu, Yunzhao Xu, Langxi Yang, Emeli Chatterjee, Guoping Li, Dragoş Crețoiu, Lijun Wang, Junjie Xiao · 2025 · Journal of Cardiovascular Translational Research
Association of the triglyceride-glucose index and its combination with obesity indices with cardio-renal-metabolic multimorbidity: two decades of follow-up in the Tehran Lipid and Glucose Study
Soroush Soraneh, Navid Ebrahimi, Soroush Masrouri, Maryam Tohidi, Fereidoun Azizi, Farzad Hadaegh · 2025 · Cardiovascular Diabetology
Physical activity and cardiovascular-metabolic disease risk across cardiovascular-kidney-metabolic syndrome stages: a population-based cohort study
Wei Feng Zhao, Qing Yan, Chuan Mou · 2025 · BMC Cardiovascular Disorders
Explainable machine learning‐driven predictive modelling of incident cognitive impairment in individuals with early‐stage cardiovascular–kidney–metabolic syndrome: Insights from a longitudinal CHARLS cohort study
Shoupeng Duan, Yijun Wang, Xiaomeng Yang, Yanan Xu, Jun Wang · 2025 · Diabetes Obesity and Metabolism
Inflammasomes as the molecular hub of cardiovascular-metabolic-immune comorbidity networks
Xingyu Qian, Jian M. Sun, Fei Li, Xu Li, Xingjian Hu, Nianguo Dong, Guangzhou Li · 2025 · Frontiers in Immunology
Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association
Karen E. Joynt Maddox, Harmony R. Reynolds, Demilade A. Adedinsewo, Cheryl Bushnell, Holli A. DeVon, Holly C. Gooding, Virginia J. Howard, Rina Mauricio, Eliza C. Miller, Garima V. Sharma et al. · 2026 · Circulation
Relevance of obesity-related organ damage and metabolic syndrome classification in cardiovascular and renal risk stratification in patients with essential hypertension
Luigi Petramala, Antonietta Gigante, Francesca Sarlo, Adriana Servello, Francesco Circosta, Luca Marino, Antonello Ciccarelli, Giuseppe Cavallaro, Claudio Letizia · 2024 · Frontiers in Cardiovascular Medicine
Phenotypes of South Asian patients with atrial fibrillation and holistic integrated care management: cluster analysis of data from KERALA-AF Registry
Yang Chen, Bi Huang, Peter A. R. Calvert, Yang Liu, Ying Xuan Gue, Dhiraj Gupta, Garry McDowell, Jinbert Lordson Azariah, Narayanan Namboodiri, Govindan Unni et al. · 2024 · The Lancet Regional Health - Southeast Asia
Liver-Kidney-Metabolic Health, Sex, and Menopause Impact Total Scores and Monovessel vs. Multivessel Coronary Artery Calcification
Kamran Bagheri Lankarani, Mohamad Jamalinia, Fatemeh Zare, Seyed Taghi Heydari, Ali Ardekani, Amedeo Lonardo · 2025 · Advances in Therapy
Prevalence of cardiovascular-kidney-metabolic syndrome in Korea: Korea National Health and Nutrition Examination Survey 2011-2021
Sung-Bin Hong, Ji-Eun Kim, Seung Seok Han, Joseph J. Shearer, Jungnam Joo, Ji‐Yeob Choi, Veronique Lee Roger · 2025 · Epidemiology and Health
Abdominal obesity and frailty progression in population across different Cardiovascular-Kidney-Metabolic syndrome stages: a nationwide longitudinal study
Chong Zhang, Cuijun Hao, Weiru Liang, Kun Hu, Tingting Guo, Yi Chen, Meng Ning, Yingwu Liu · 2025 · Diabetology & Metabolic Syndrome
U-shaped relationship of estimated glucose disposal rate with cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stages 0–3: a population-based prospective study
Xiaomin Liang, Kai Lai, Xiaohong Li, Shuiqing Gui, Zemao Xing, Ying Li · 2025 · Diabetology & Metabolic Syndrome
Glycemic Targets and Prevention of Complications
Yumiko Tsushima, Nicholas Galloway · 2025 · The Journal of Clinical Endocrinology & Metabolism
Stress hyperglycemia ratio as an independent predictor of acute kidney injury in critically ill patients with acute myocardial infarction: a retrospective U.S. cohort study
Xudong Li, Yong Qiao, Liang Ruan, Shuailei Xu, Zhongguo Fan, Shiqi Liu, Junxian Shen, Chengchun Tang, Yuhan Qin · 2025 · Renal Failure
Dried Blood Spots to Assess Cardiovascular‐Kidney‐Metabolic Health
Tyler Jacobson, Kian J. Rahbari, William Alexander Henry Schwartz, Yeunook Bae, Runze Zhang, Denise Nunes, Cathelin Huang, Ramzy P. Issa, Karen R. Smilowitz, Lily Du Yan et al. · 2025 · Journal of the American Heart Association
Cardiovascular risk and chronic kidney disease: strategies for cardiac and renal protection. Interdisciplinary consensus
Oksana M. Drapkina, Zhanna D. Kobalava, Marina Vladimirovna Shestakova, Irina Nikolaevna Bobkova, Ефремовцева Марина Алексеевна, Виллевальде Светлана Вадимовна, М. М. Batyushin, Yu. N. Belenkov, Andrey Vatazin, Albert S. Galyavich et al. · 2025 · CARDIOVASCULAR THERAPY AND PREVENTION
Definition, Classification, Diagnosis, and Management of an Emerging Threat: Cardio-Renal-Metabolic Syndrome
Theocharis Koufakis, Demetrios Vlahakos, Charalambos Vlachopoulos, Emmanouil Kallistratos, Kalliopi Kotsa, Evangelos N. Liberopoulos, Ioannis Stefanidis, Erifili E. Hatziagelaki · 2025 · American Journal of Cardiovascular Drugs
Novel Anthropometric Indices: An Allometric Perspective
Nir Y. Krakauer, Jesse C. Krakauer · 2025 · Endocrines
Connecting the Dots: Hepatic Steatosis as a Central Player in the Choreography of the Liver-Cardiovascular-Kidney-Metabolic Syndrome
Richard H. Goodheart, Oyekoya Taiwo Ayonrinde · 2025 · Heart Lung and Circulation
Monocyte-to-HDL ratio (MHR) as a novel biomarker: reference ranges and associations with inflammatory diseases and disease-specific mortality
Ahmed Arabi, Alaa Abdelhamid, Dima Nasrallah, Yaman Al-Haneedi, Deemah Assami, Raneem Alnassif Alsheikh, Susu M. Zughaier · 2025 · Lipids in Health and Disease
Trends in Prevalence, Treatment, and Control of Cardiometabolic Risk Factors Among Adults With Hypertension in the United States, 1999-2023
Hyeok‐Hee Lee, Emily B. Crawford, So Mi Jemma Cho, Anna Katherine Krawisz, Stephen P. Juraschek, Jennifer Cluett, Hokyou Lee, Hyeon Chang Kim, Pradeep Natarajan, Rishi K. Wadhera et al. · 2025 · Journal of the American College of Cardiology
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease
Radica Z. Alicic, Joshua J. Neumiller, Katherine R. Tuttle · 2026 · Nature Reviews Nephrology
Association between the combined c-reactive protein-triglyceride glucose index and hypertension with long-term stroke among cardiovascular-kidney-metabolic syndrome stages 0–3 population: a nationwide prospective cohort study
Ze‐Jiaxin Niu, Zi-ang Liu, Tian Wei, Meng Dou, Puxun Tian, Ying Cui · 2026 · Cardiovascular Diabetology
Associations of triglyceride–glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis
Hui Liu, Feng Guo, Hongjia Fu, Xin Xu, Zengyu Wang, Jialu Kang, Jiangxue Feng, Yongqing Shen, Wei Liu · 2026 · Cardiovascular Diabetology
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?
Óscar Moreno, Rebeca Reyes‐García, Inés Modrego Pardo, Marina López-Martínez, María José Soler · 2024 · Clinical Kidney Journal
The Impact of the Aryl Hydrocarbon Receptor on Antenatal Chemical Exposure-Induced Cardiovascular–Kidney–Metabolic Programming
You‐Lin Tain, Chien‐Ning Hsu · 2024 · International Journal of Molecular Sciences
Role of Ectopic Olfactory Receptors in the Regulation of the Cardiovascular–Kidney–Metabolic Axis
Mitchell Beito, Sadia Ashraf, Dorcas Odogwu, Romain Harmancey · 2024 · Life
Medicare Coverage and Patient Out-of-Pocket Costs for Cardiovascular-Kidney-Metabolic Medications
Grant M. Young, Kannu Bansal, Ralph J. Riello, Katherine A. A. Clark, Sanket Shishir Dhruva, Kamil F. Faridi, Nihar R. Desai · 2024 · JAMA Network Open
The prognostic value of metabolic dysfunction‐associated steatotic liver disease in acute myocardial infarction: A propensity score‐matched analysis
Gwyneth Kong, Grace Cao, Jaycie Koh, Siew Pang Chan, Audrey A. Y. Zhang, Esther S.P. Wong, Bryan Chong, Silingga Metta Jauhari, Jiong‐Wei Wang, Anurag Mehta et al. · 2024 · Diabetes Obesity and Metabolism
CMR to characterize myocardial structure and function in heart failure with preserved left ventricular ejection fraction
Rojda Ipek, Jennifer Holland, Mareike Gastl, Oliver J. Rider · 2024 · European Heart Journal - Cardiovascular Imaging
The impact of the triglyceride-glucose index on the deterioration of kidney function in patients with cardiovascular-kidney-metabolic syndrome: insight from a large cohort study in China
Zhi Shang, Songtao Feng, Hui Qian, Zhenling Deng, Yue Wang, Yue-Ming Gao · 2025 · Renal Failure
Longitudinal Changes in Cardiovascular-Kidney-Metabolic Syndrome Stages and Their Impact on Outcomes: A Nationwide Cohort Study
Byung Sik Kim, Hyun‐Jin Kim, Hasung Kim, Jungkuk Lee, Jeong‐Hun Shin, Ki‐Chul Sung · 2025 · Journal of Clinical Medicine
The Role of Race in Cardiovascular Disease Risk Prediction
Chiadi E. Ndumele, Keith C. Ferdinand, Sadiya S. Khan · 2025 · Circulation
Molecular and Functional Significance of Growth Differentiation Factor-15: A Review on Cardiovascular-Kidney-Metabolic Biomarker
Krishna Tiwari, Aswini Saravanan, Abhishek Anil, Vikas Kumar Tiwari, Muhammad Aaqib Shamim, Surjit Singh, Pradeep Dwivedi, Surender Deora, Shoban Babu Varthya · 2025 · Current Cardiology Reviews
From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease
Razvan George Bogdan, Adrian Boicean, Paula Anderco, Cristian Ichim, Mihai Iliescu-Glaja, Samuel Bogdan Todor, Elisa Leonte, Vlad Bloancă, Zorin Petrişor Crăiniceanu, Mirela Livia Popa · 2025 · Journal of Clinical Medicine
Relationship between estimated pulse wave velocity trajectories and cardiovascular disease risk in patients with cardiovascular-kidney-metabolic syndrome stages 0–3
Tingting Chen, Huangyi Yin, Yubo Zhou, Min Liang · 2025 · Nutrition Metabolism and Cardiovascular Diseases
Obesity-Related Kidney Disease: A Growing Threat to Renal Health
Juan Carlos León-Román, Marina López-Martínez, Alexandra Esteves, Andreea Ciudin, Sara Núñez-Delgado, Tiffany Álvarez, Albert Lecube, Jorge E. Rico-Fontalvo, María José Soler · 2025 · International Journal of Molecular Sciences
The efficacy and safety of glucagon-like peptide-1 receptor agonists in non-diabetic adults with overweight/obesity: An umbrella review of systematic reviews and meta-analyses
Nazanin Zamanian, Hossein Imani, Sepide Talebi, Mehran Rahimlou, Reza Amiri Khosroshahi, Hamed Mohammadi · 2025 · European Journal of Pharmacology
Cardiovascular–kidney–metabolic syndrome and mortality in a prospective UK cohort study
Kaitlin J. Mayne, Heather Walker, Benjamin Michael Peter Elyan, Patrick Barry Mark, Paul I. Welsh, Ninian N. Lang, Naveed A. Sattar, Jill P. Pell, Frederick Ka Wing Ho, Jennifer Susan Lees · 2025 · European Journal of Preventive Cardiology
Comparison of triglyceride-glucose index and triglyceride-glucose related indexes in predicting cardiovascular disease incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study
Qingsong Mao, Nianzhou Liu, Tian Xiong, Xinyi Wang, Xinling Tian, Yuzhe Kong · 2025 · Frontiers in Endocrinology · Retracted
Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Sadiya S. Khan, Marwah Abdalla, Natalie Ann Bello, Ciantel Adair Blyler, Jocelyn Carter, Yvonne Y Commodore-Mensah, Keith C. Ferdinand, Heather M. Johnson, Daniel W. Jones, Amit Khera et al. · 2025 · Hypertension
Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real‐world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)
Kim G. E. Smolderen, Carlos Mena‐Hurtado, Zhenxiang Zhao, Wojciech Michalak, Mads D. Faurby, B. Gabriel Smolarz, Mikhail Kosiborod, Jinlin Song, Yan Chen, Joanna Boland et al. · 2025 · Diabetes Obesity and Metabolism
ERA’s ABCDE framework for kidney disease prevention: turning the WHO kidney health resolution into action
Roser Torrá, Dimitrios S. Goumenos, Mustafa Arici, Alberto Ortiz, Marcin Adamczak, Kathrin Eller, Ana Carina Ferreira, Giuseppe Grandaliano, Kitty J. Jager, Jennifer Susan Lees et al. · 2025 · Nephrology Dialysis Transplantation
Asia at the Epicenter of the Global Cardiometabolic Shift
Shaun Khanna, Gary C. H. Gan, Andrew Paul Sindone, Jasper Tromp, Javed Butler, Roger Foo, Nitesh Nerlekar, Aditya Bhat · 2026 · JACC Asia
Exercise for chronic kidney disease: effects on vascular and cardiopulmonary function
Danielle L. Kirkman, Domenico A. Chavez · 2023 · American Journal of Physiology-Heart and Circulatory Physiology
Chinese visceral adiposity index and its transition patterns: impact on cardiovascular and cerebrovascular diseases in a national cohort study
Zhihan Lv, Yunxi Ji, Su Xu, Chenyi Li, Wenwei Cai · 2024 · Lipids in Health and Disease
Comprehensive assessment of cardiovascular-kidney-metabolic (CKM) syndrome: Novel tools for assessment of cardiovascular risk and kidney outcomes in long-term kidney transplant patients
Krzysztof Batko, Anna Sączek, Małgorzata Banaszkiewicz, Jolanta Małyszko, Ewa Koc‐Żórawska, Marcin Żórawski, Karolina Niezabitowska, Katarzyna Siek, Alina Bętkowska-Prokop, Jacek Małyszko et al. · 2024 · Kardiologia Polska
Metabolically “extremely unhealthy” obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project
Oliwia Janota, Marta Mantovani, Hanna Kwiendacz, Krzysztof Irlik, Tommaso Bucci, Steven Ho Man Lam, Bi Huang, Uazman Alam, Giuseppe Boriani, Mirela Hendel et al. · 2024 · Cardiovascular Diabetology
Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop
L. Pearce, Carlos Galán‐Arriola, RM Bell, Richard David Carr, J. Cunningham, Sean M. Davidson, Arjun Kumar Ghosh, Sara Giesz, Pelin Arabacilar Golforoush, Alexander V. Gourine et al. · 2024 · Basic Research in Cardiology
Characteristics of patients with undiagnosed stage 3 chronic kidney disease: results from an observational study (REVEAL-CKD) in China
Sheng Nie, Shi-Yu Zhou, Claudia S. Cabrera, Shan Chen, Mengyun Jia, Shiyu Zhang, Licong Su, Qi Gao, Navdeep Tangri, Fan Fan Hou · 2025 · The Lancet Regional Health - Western Pacific
Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders
Shihan Zhang, Shasha Tang, Yalei Liu, Binghua Xue, Qinyuan Xie, Lingyun Zhao, Huijuan Yuan · 2025 · Frontiers in Endocrinology
Association between Chinese visceral adiposity index and cardiovascular events risk in individuals with cardiovascular–kidney–metabolic syndrome stage 0–3: a nationwide cohort study
Xiaobo Shen, Qi Liu, Tianchen Lin, Danna Zheng, Qiang He · 2025 · International Urology and Nephrology
Association between atherogenic index of plasma and future cardiovascular disease risk in middle-aged and elderly individuals with cardiovascular-kidney-metabolic syndrome stage 0-3
Lin Ya, Xiaodong Lv, Ce Shi, Ting Wang, Zehao Jin, Qiangsong Jin, Chao Gu · 2025 · Frontiers in Endocrinology
Association between triglyceride glucose body mass index and 1 year all cause mortality in stage 4 CKM syndrome patients
Wen Harn Pan, Teng-fei Ji, Bing Hu, Jing Yang, Lei Lu, Jin jia Wei · 2025 · Scientific Reports
Utility of HFpEF Diagnostic Scores to Stratify Cardiac Reserve Among Patients With Dyspnea
Tatsuro Ibe, Yogesh N.V. Reddy, Tomonari Harada, Shunichi Doi, Atsushi Tada, Jwan A. Naser, Ryan T. Demmer, Barry A. Borlaug · 2025 · JACC Heart Failure
Large-Scale Proteomics-Based Risk Score for the Prediction of Incident Cardio-Kidney-Metabolic Disease Risk
ADITHYA K. YADALAM, Chang Liu, Qin Hui, Alexander C. Razavi, Laurence S. Sperling, Arshed Ali Quyyumi, Yan V. Sun · 2025 · Circulation Genomic and Precision Medicine
Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease
Hokyou Lee, Xiaoning Huang, Sadiya S. Khan, Dasom Son, Hyeok-Hee Lee, Eun‐Jin Kim, Donald M. Lloyd‐Jones, Hyeon Chang Kim, Philip Greenland · 2025 · Journal of the American College of Cardiology
Inflammation and abnormal glucose-lipid metabolism are critical for population stratification toward progressive frailty in Cardiovascular-Kidney-Metabolic syndrome
Chong Zhang, Yi Chen, Tianqi Wang, Wenjin Peng, Meng Ning, Yingwu Liu · 2025 · Diabetes Research and Clinical Practice
Cardiovascular-kidney-metabolic: Hype or a focus on front-line health?
Xinyi Cai, Hao Huang, Tuo Li · 2025 · Journal of Translational Internal Medicine
Readiness to deliver integrated cardiovascular, kidney and metabolic care in primary healthcare: phase II of HEARTS 2.0 in 26 countries in the Americas
Pedro Ordúñez, Andrés Rosende, Jeffrey W. Brettler, Esteban Londoño Agudelo, Patrick Van der Stuyft, Ramon Martinez-Piedra, Libardo Rodríguez, Mariana Lizbeth Rodríguez de la Cerda, Kerry-Ann Renaud-Thomas, Vicente Aleixandre Benites-Zapata et al. · 2026 · BMJ Global Health
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects
Hussein Zaitoon, Muhammad A Abdul‐Ghani, Ralph A. DeFronzo · 2026 · Nature Reviews Nephrology
Global Prevalence, Incidence, and Outcomes of Coexisting MASLD and Chronic Kidney Disease: A Meta‐Analysis
Martin Tze Wah Kueh, J Q Yeo, Yiming Chen, Nicole Ying Zi Chua, Hui Lian Koh, Seng Pei Khaw, Hassan Jabbar, Jiong‐Wei Wang, Kwan Seung S Lee, Yip Han Chin et al. · 2026 · Liver International
Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease
Christine P. Limonte, Julio Alejandro Lamprea-Montealegre, Katherine R. Tuttle · 2024 · Seminars in Nephrology
Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof‐of‐concept results from the DECIDE ‐ CV clinical programme
Pedro Sousa Marques, Thomas A. Mavrakanas, Julian Guida, Tara Gédéon, Anahita Emami, Abdulkhaliq Alaamiri, Daniel Ho, Elite Possik, Guang K. Zhang, Michael A. Tsoukas et al. · 2024 · Diabetes Obesity and Metabolism
The 2024 American Diabetes Association guidelines on Standards of Medical Care in Diabetes: key takeaways for laboratory
Dipti Tiwari, Tar Choon Aw · 2024 · Exploration of Endocrine and Metabolic Diseases
Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023
Ying Wang, Tongtong Liu, Weijing Liu, Hailing Zhao, Ping Li · 2024 · Frontiers in Pharmacology